Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Innate Pharma S.A. (FR:IPH)
:IPH
Holding FR:IPH?
Track your performance easily
IPH Stock Chart & Stats
Day’s Range― - ―
52-Week Range€1.33 - €2.79
Previous CloseN/A
Volume28.41K
Average Volume (3M)214.59K
Market Cap
€145.83M
Enterprise Value€95.26M
Total Cash (Recent Filing)$202.89M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.72
Next Earnings
Mar 27, 2025EPS Estimate
-0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.42
Shares Outstanding83,830,340
10 Day Avg. Volume114,227
30 Day Avg. Volume214,593
Standard Deviation0.17
R-Squared0.05
Alpha-0.00884
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.24
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap0.65
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.55
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€3.20Price Target Upside84.97% Upside
Rating ConsensusHold
Number of Analyst Covering1
Innate Pharma S.A. News
PremiumCompany Announcements
Innate Pharma to Showcase ADC Innovations at Upcoming New York Event
PremiumCompany Announcements
Innate Pharma Reports Share and Voting Rights Update
PremiumCompany Announcements
Innate Pharma Unveils Growth Strategy Focused on Innovation and Partnerships
PremiumCompany Announcements
Innate Pharma to Present at J.P. Morgan Healthcare Conference
PremiumCompany Announcements
Innate Pharma SA Reveals Promising Lacutamab Trial ResultsOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.03% Other Institutional Investors
99.94% Public Companies and
Individual Investors
IPH FAQ
What was Innate Pharma S.A.’s price range in the past 12 months?
Innate Pharma S.A. lowest stock price was €1.33 and its highest was €2.79 in the past 12 months.
What is Innate Pharma S.A.’s market cap?
Innate Pharma S.A.’s market cap is €145.83M.
When is Innate Pharma S.A.’s upcoming earnings report date?
Innate Pharma S.A.’s upcoming earnings report date is Mar 27, 2025 which is in 64 days.
How were Innate Pharma S.A.’s earnings last quarter?
Innate Pharma S.A. released its earnings results on Sep 12, 2024. The company reported -€0.31 earnings per share for the quarter, missing the consensus estimate of -€0.28 by -€0.03.
Is Innate Pharma S.A. overvalued?
According to Wall Street analysts Innate Pharma S.A.’s price is currently Undervalued.
Does Innate Pharma S.A. pay dividends?
Innate Pharma S.A. does not currently pay dividends.
What is Innate Pharma S.A.’s EPS estimate?
Innate Pharma S.A.’s EPS estimate is -0.26.
How many shares outstanding does Innate Pharma S.A. have?
Innate Pharma S.A. has 83,830,340 shares outstanding.
What happened to Innate Pharma S.A.’s price movement after its last earnings report?
Innate Pharma S.A. reported an EPS of -€0.31 in its last earnings report, missing expectations of -€0.28. Following the earnings report the stock price went down -2.752%.
Which hedge fund is a major shareholder of Innate Pharma S.A.?
Currently, no hedge funds are holding shares in FR:IPH
---
Company Description
Innate Pharma S.A.
Innate Pharma SA is a biopharmaceutical company, which focuses on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. Its products include immunotherapy drugs and monoclonal antibodies. The Immunotherapy drugs are designated for cancer and inflammatory diseases. The Monoclonal antibodies targets receptors and pathways controlling the activation of innate immunity cells. The company was founded by Hervé Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fournié and François Romagné on September 15, 1999 and is headquartered in Marseille, France.
---
IPH Company Deck
---
IPH Earnings Call
Q2 2024
0:00 / 0:00
---
Technical Analysis
---